BMO Q1 2026 Earnings Profit Beat Drives Modest Share Gains FSV Q1 2026 Earnings EPS Surpasses Estimates by Over 6 ODD Q4 2025 Earnings EPS Surges Past Estimates as Profitability Improves GPUS Q3 2025 Earnings Loss Per Share of 039 Highlights Ongoing PreRevenue Status GT Biopharma Q1 2026 Earnings Wider Loss and No Revenue as Pipeline Progress Remains Uncertain CCID Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher